APO Research

APO RESEARCH · REPORT

Cinnarizine

Selected research

Industry Growth & Trends

Global Cinnarizine Industry Growth and Trends Forecast to 2032

Market perspective

The global Cinnarizine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cinnarizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cinnarizine include Teva, Johnson And Johnson, Novartis, Mylan, Zambon, Sopharma, Nidda Healthcare, March Pharma and Leti Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cinnarizine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cinnarizine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cinnarizine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cinnarizine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cinnarizine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cinnarizine Market by Company

Teva

Johnson And Johnson

Novartis

Mylan

Zambon

Sopharma

Nidda Healthcare

March Pharma

Leti Pharma

Inga Laboratories

Hasco-Lek

Goodwill Pharma

Gedeon Richter

Eurogenerics

Aurobindo Pharma

Apotex

Allena Pharmaceuticals

Cinnarizine Segment by Type

On-line

Drug Store

Hospital

Cinnarizine Segment by Application

Histamine H₁-Receptor Antagonist

Antiemetic Agent

Antivertigo Agent

Cinnarizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cinnarizine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cinnarizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of On-line Table 2. Major Company of Drug Store Table 3. Major Company of Hospital Table 4. Global Cinnarizine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cinnarizine Sales by Type (2021-2026) & (K Units) Table 6. Global Cinnarizine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cinnarizine Sales Market Share in Value by Type (2021-2026) Table 9. Global Cinnarizine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cinnarizine Sales by Type (2027-2032) & (K Units) Table 11. Global Cinnarizine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cinnarizine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cinnarizine Sales Market Share in Value by Type (2027-2032) Table 14. Global Cinnarizine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cinnarizine Sales by Type (2021-2026) & (K Units) Table 16. North America Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cinnarizine Sales by Type (2021-2026) & (K Units) Table 18. Europe Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cinnarizine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cinnarizine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cinnarizine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Cinnarizine Sales by Type (2021-2026) & (US$ Million) Table 25. Cinnarizine Industry Trends Table 26. Cinnarizine Industry Drivers Table 27. Cinnarizine Industry Opportunities and Challenges Table 28. Cinnarizine Industry Restraints Table 29. Global Cinnarizine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cinnarizine Revenue Market Share by Company (2021-2026) Table 31. Global Cinnarizine Sales by Company (2021-2026) & (K Units) Table 32. Global Cinnarizine Sales Share by Company (2021-2026) Table 33. Global Cinnarizine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cinnarizine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cinnarizine Major Company Production Sites and Headquarters Table 36. Global Cinnarizine Company, Product Type & Application Table 37. Global Cinnarizine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cinnarizine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cinnarizine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cinnarizine Sales by Region (2021-2026) & (K Units) Table 42. Global Cinnarizine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cinnarizine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cinnarizine Sales Market Share in Value by Region (2021-2026) Table 45. Global Cinnarizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cinnarizine Sales by Region (2027-2032) & (K Units) Table 47. Global Cinnarizine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cinnarizine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cinnarizine Sales Market Share in Value by Region (2027-2032) Table 50. Global Cinnarizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cinnarizine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cinnarizine Sales by Application (2021-2026) & (K Units) Table 53. Global Cinnarizine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cinnarizine Sales Market Share in Value by Application (2021-2026) Table 56. Global Cinnarizine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cinnarizine Sales by Application (2027-2032) & (K Units) Table 58. Global Cinnarizine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cinnarizine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cinnarizine Sales Market Share in Value by Application (2027-2032) Table 61. Global Cinnarizine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cinnarizine Sales by Application (2021-2026) & (K Units) Table 63. North America Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cinnarizine Sales by Application (2021-2026) & (K Units) Table 65. Europe Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cinnarizine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cinnarizine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cinnarizine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Cinnarizine Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Cinnarizine Product Portfolio Table 76. Teva Recent Development Table 77. Johnson And Johnson Company Information Table 78. Johnson And Johnson Business Overview Table 79. Johnson And Johnson Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson And Johnson Cinnarizine Product Portfolio Table 81. Johnson And Johnson Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novartis Cinnarizine Product Portfolio Table 86. Novartis Recent Development Table 87. Mylan Company Information Table 88. Mylan Business Overview Table 89. Mylan Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Mylan Cinnarizine Product Portfolio Table 91. Mylan Recent Development Table 92. Zambon Company Information Table 93. Zambon Business Overview Table 94. Zambon Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zambon Cinnarizine Product Portfolio Table 96. Zambon Recent Development Table 97. Sopharma Company Information Table 98. Sopharma Business Overview Table 99. Sopharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sopharma Cinnarizine Product Portfolio Table 101. Sopharma Recent Development Table 102. Nidda Healthcare Company Information Table 103. Nidda Healthcare Business Overview Table 104. Nidda Healthcare Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Nidda Healthcare Cinnarizine Product Portfolio Table 106. Nidda Healthcare Recent Development Table 107. March Pharma Company Information Table 108. March Pharma Business Overview Table 109. March Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. March Pharma Cinnarizine Product Portfolio Table 111. March Pharma Recent Development Table 112. Leti Pharma Company Information Table 113. Leti Pharma Business Overview Table 114. Leti Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Leti Pharma Cinnarizine Product Portfolio Table 116. Leti Pharma Recent Development Table 117. Inga Laboratories Company Information Table 118. Inga Laboratories Business Overview Table 119. Inga Laboratories Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Inga Laboratories Cinnarizine Product Portfolio Table 121. Inga Laboratories Recent Development Table 122. Hasco-Lek Company Information Table 123. Hasco-Lek Business Overview Table 124. Hasco-Lek Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Hasco-Lek Cinnarizine Product Portfolio Table 126. Hasco-Lek Recent Development Table 127. Goodwill Pharma Company Information Table 128. Goodwill Pharma Business Overview Table 129. Goodwill Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Goodwill Pharma Cinnarizine Product Portfolio Table 131. Goodwill Pharma Recent Development Table 132. Gedeon Richter Company Information Table 133. Gedeon Richter Business Overview Table 134. Gedeon Richter Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Gedeon Richter Cinnarizine Product Portfolio Table 136. Gedeon Richter Recent Development Table 137. Eurogenerics Company Information Table 138. Eurogenerics Business Overview Table 139. Eurogenerics Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Eurogenerics Cinnarizine Product Portfolio Table 141. Eurogenerics Recent Development Table 142. Aurobindo Pharma Company Information Table 143. Aurobindo Pharma Business Overview Table 144. Aurobindo Pharma Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Aurobindo Pharma Cinnarizine Product Portfolio Table 146. Aurobindo Pharma Recent Development Table 147. Apotex Company Information Table 148. Apotex Business Overview Table 149. Apotex Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Apotex Cinnarizine Product Portfolio Table 151. Apotex Recent Development Table 152. Allena Pharmaceuticals Company Information Table 153. Allena Pharmaceuticals Business Overview Table 154. Allena Pharmaceuticals Cinnarizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Allena Pharmaceuticals Cinnarizine Product Portfolio Table 156. Allena Pharmaceuticals Recent Development Table 157. North America Cinnarizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. North America Cinnarizine Sales by Country (2021-2026) & (K Units) Table 159. North America Cinnarizine Sales Market Share by Country (2021-2026) Table 160. North America Cinnarizine Sales Forecast by Country (2027-2032) & (K Units) Table 161. North America Cinnarizine Sales Market Share Forecast by Country (2027-2032) Table 162. North America Cinnarizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. North America Cinnarizine Market Size by Country (2021-2026) & (US$ Million) Table 164. North America Cinnarizine Market Share by Country (2021-2026) Table 165. North America Cinnarizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. North America Cinnarizine Market Share Forecast by Country (2027-2032) Table 167. Europe Cinnarizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Europe Cinnarizine Sales by Country (2021-2026) & (K Units) Table 169. Europe Cinnarizine Sales Market Share by Country (2021-2026) Table 170. Europe Cinnarizine Sales Forecast by Country (2027-2032) & (K Units) Table 171. Europe Cinnarizine Sales Market Share Forecast by Country (2027-2032) Table 172. Europe Cinnarizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Europe Cinnarizine Market Size by Country (2021-2026) & (US$ Million) Table 174. Europe Cinnarizine Market Share by Country (2021-2026) Table 175. Europe Cinnarizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Europe Cinnarizine Market Share Forecast by Country (2027-2032) Table 177. Asia-Pacific Cinnarizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Asia-Pacific Cinnarizine Sales by Country (2021-2026) & (K Units) Table 179. Asia-Pacific Cinnarizine Sales Market Share by Country (2021-2026) Table 180. Asia-Pacific Cinnarizine Sales Forecast by Country (2027-2032) & (K Units) Table 181. Asia-Pacific Cinnarizine Sales Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Cinnarizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Cinnarizine Market Size by Country (2021-2026) & (US$ Million) Table 184. Asia-Pacific Cinnarizine Market Share by Country (2021-2026) Table 185. Asia-Pacific Cinnarizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Asia-Pacific Cinnarizine Market Share Forecast by Country (2027-2032) Table 187. Latin America Cinnarizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Latin America Cinnarizine Sales by Country (2021-2026) & (K Units) Table 189. Latin America Cinnarizine Sales Market Share by Country (2021-2026) Table 190. Latin America Cinnarizine Sales Forecast by Country (2027-2032) & (K Units) Table 191. Latin America Cinnarizine Sales Market Share Forecast by Country (2027-2032) Table 192. Latin America Cinnarizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Latin America Cinnarizine Market Size by Country (2021-2026) & (US$ Million) Table 194. Latin America Cinnarizine Market Share by Country (2021-2026) Table 195. Latin America Cinnarizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Latin America Cinnarizine Market Share Forecast by Country (2027-2032) Table 197. Middle East and Africa Cinnarizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 198. Middle East and Africa Cinnarizine Sales by Country (2021-2026) & (K Units) Table 199. Middle East and Africa Cinnarizine Sales Market Share by Country (2021-2026) Table 200. Middle East and Africa Cinnarizine Sales Forecast by Country (2027-2032) & (K Units) Table 201. Middle East and Africa Cinnarizine Sales Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Cinnarizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Cinnarizine Market Size by Country (2021-2026) & (US$ Million) Table 204. Middle East and Africa Cinnarizine Market Share by Country (2021-2026) Table 205. Middle East and Africa Cinnarizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 206. Middle East and Africa Cinnarizine Market Share Forecast by Country (2027-2032) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Cinnarizine Distributors List Table 210. Cinnarizine Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Cinnarizine Image Figure 2. Global Cinnarizine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cinnarizine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cinnarizine Sales (2021-2032) & (K Units) Figure 5. On-line Image Figure 6. Global On-line Sales YoY Growth (2021-2032) & (K Units) Figure 7. Drug Store Image Figure 8. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 9. Hospital Image Figure 10. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Cinnarizine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cinnarizine Market Share by Type 2025 VS 2032 Figure 13. North America Cinnarizine Sales Market Share in Volume by Type in 2025 Figure 14. North America Cinnarizine Sales Market Share in Value by Type in 2025 Figure 15. Europe Cinnarizine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cinnarizine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cinnarizine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cinnarizine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cinnarizine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cinnarizine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cinnarizine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cinnarizine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cinnarizine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Histamine H₁-Receptor Antagonist Image Figure 26. Global Histamine H₁-Receptor Antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 27. Antiemetic Agent Image Figure 28. Global Antiemetic Agent Sales YoY Growth (2021-2032) & (K Units) Figure 29. Antivertigo Agent Image Figure 30. Global Antivertigo Agent Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cinnarizine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cinnarizine Market Share by Application 2025 VS 2032 Figure 33. North America Cinnarizine Sales Market Share in Volume by Application in 2025 Figure 34. North America Cinnarizine Sales Market Share in Value by Application in 2025 Figure 35. Europe Cinnarizine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cinnarizine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cinnarizine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cinnarizine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cinnarizine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cinnarizine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cinnarizine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cinnarizine Sales Market Share in Value by Application in 2025 Figure 43. North America Cinnarizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cinnarizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cinnarizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cinnarizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cinnarizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cinnarizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cinnarizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cinnarizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cinnarizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cinnarizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cinnarizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cinnarizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cinnarizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cinnarizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cinnarizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cinnarizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cinnarizine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cinnarizine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • On-line
  • Drug Store
  • Hospital
Applications
  • Histamine H₁-Receptor Antagonist
  • Antiemetic Agent
  • Antivertigo Agent
Companies covered
  • Teva
  • Johnson And Johnson
  • Novartis
  • Mylan
  • Zambon
  • Sopharma
  • Nidda Healthcare
  • March Pharma
  • Leti Pharma
  • Inga Laboratories
  • Hasco-Lek
  • Goodwill Pharma
  • Gedeon Richter
  • Eurogenerics
  • Aurobindo Pharma
  • Apotex
  • Allena Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cinnarizine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cinnarizine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cinnarizine Market by Type
  6. 1.3.1 On-line
  7. 1.3.2 Drug Store
  8. 1.3.3 Hospital
  9. 1.4 Global Cinnarizine Market Size by Type
  10. 1.4.1 Global Cinnarizine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cinnarizine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cinnarizine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cinnarizine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cinnarizine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cinnarizine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cinnarizine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cinnarizine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cinnarizine Industry Trends
  2. 2.2 Cinnarizine Industry Drivers
  3. 2.3 Cinnarizine Industry Opportunities and Challenges
  4. 2.4 Cinnarizine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cinnarizine Revenue (2021-2026)
  2. 3.2 Global Top Players by Cinnarizine Sales (2021-2026)
  3. 3.3 Global Top Players by Cinnarizine Price (2021-2026)
  4. 3.4 Global Cinnarizine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cinnarizine Major Company Production Sites & Headquarters
  6. 3.6 Global Cinnarizine Company, Product Type & Application
  7. 3.7 Global Cinnarizine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cinnarizine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cinnarizine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cinnarizine Tier 1, Tier 2, and Tier 3
4 Cinnarizine Regional Status and Outlook
  1. 4.1 Global Cinnarizine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cinnarizine Historic Market Size by Region
  3. 4.2.1 Global Cinnarizine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cinnarizine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cinnarizine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cinnarizine Forecasted Market Size by Region
  7. 4.3.1 Global Cinnarizine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cinnarizine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cinnarizine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cinnarizine by Application
  1. 5.1 Cinnarizine Market by Application
  2. 5.1.1 Histamine H₁-Receptor Antagonist
  3. 5.1.2 Antiemetic Agent
  4. 5.1.3 Antivertigo Agent
  5. 5.2 Global Cinnarizine Market Size by Application
  6. 5.2.1 Global Cinnarizine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cinnarizine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cinnarizine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cinnarizine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cinnarizine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cinnarizine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cinnarizine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cinnarizine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Cinnarizine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Johnson And Johnson
  8. 6.2.1 Johnson And Johnson Company Information
  9. 6.2.2 Johnson And Johnson Business Overview
  10. 6.2.3 Johnson And Johnson Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson And Johnson Cinnarizine Product Portfolio
  12. 6.2.5 Johnson And Johnson Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Cinnarizine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Cinnarizine Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Zambon
  26. 6.5.1 Zambon Company Information
  27. 6.5.2 Zambon Business Overview
  28. 6.5.3 Zambon Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zambon Cinnarizine Product Portfolio
  30. 6.5.5 Zambon Recent Developments
  31. 6.6 Sopharma
  32. 6.6.1 Sopharma Company Information
  33. 6.6.2 Sopharma Business Overview
  34. 6.6.3 Sopharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sopharma Cinnarizine Product Portfolio
  36. 6.6.5 Sopharma Recent Developments
  37. 6.7 Nidda Healthcare
  38. 6.7.1 Nidda Healthcare Company Information
  39. 6.7.2 Nidda Healthcare Business Overview
  40. 6.7.3 Nidda Healthcare Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nidda Healthcare Cinnarizine Product Portfolio
  42. 6.7.5 Nidda Healthcare Recent Developments
  43. 6.8 March Pharma
  44. 6.8.1 March Pharma Company Information
  45. 6.8.2 March Pharma Business Overview
  46. 6.8.3 March Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 March Pharma Cinnarizine Product Portfolio
  48. 6.8.5 March Pharma Recent Developments
  49. 6.9 Leti Pharma
  50. 6.9.1 Leti Pharma Company Information
  51. 6.9.2 Leti Pharma Business Overview
  52. 6.9.3 Leti Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Leti Pharma Cinnarizine Product Portfolio
  54. 6.9.5 Leti Pharma Recent Developments
  55. 6.10 Inga Laboratories
  56. 6.10.1 Inga Laboratories Company Information
  57. 6.10.2 Inga Laboratories Business Overview
  58. 6.10.3 Inga Laboratories Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Inga Laboratories Cinnarizine Product Portfolio
  60. 6.10.5 Inga Laboratories Recent Developments
  61. 6.11 Hasco-Lek
  62. 6.11.1 Hasco-Lek Company Information
  63. 6.11.2 Hasco-Lek Business Overview
  64. 6.11.3 Hasco-Lek Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hasco-Lek Cinnarizine Product Portfolio
  66. 6.11.5 Hasco-Lek Recent Developments
  67. 6.12 Goodwill Pharma
  68. 6.12.1 Goodwill Pharma Company Information
  69. 6.12.2 Goodwill Pharma Business Overview
  70. 6.12.3 Goodwill Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Goodwill Pharma Cinnarizine Product Portfolio
  72. 6.12.5 Goodwill Pharma Recent Developments
  73. 6.13 Gedeon Richter
  74. 6.13.1 Gedeon Richter Company Information
  75. 6.13.2 Gedeon Richter Business Overview
  76. 6.13.3 Gedeon Richter Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Gedeon Richter Cinnarizine Product Portfolio
  78. 6.13.5 Gedeon Richter Recent Developments
  79. 6.14 Eurogenerics
  80. 6.14.1 Eurogenerics Company Information
  81. 6.14.2 Eurogenerics Business Overview
  82. 6.14.3 Eurogenerics Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Eurogenerics Cinnarizine Product Portfolio
  84. 6.14.5 Eurogenerics Recent Developments
  85. 6.15 Aurobindo Pharma
  86. 6.15.1 Aurobindo Pharma Company Information
  87. 6.15.2 Aurobindo Pharma Business Overview
  88. 6.15.3 Aurobindo Pharma Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aurobindo Pharma Cinnarizine Product Portfolio
  90. 6.15.5 Aurobindo Pharma Recent Developments
  91. 6.16 Apotex
  92. 6.16.1 Apotex Company Information
  93. 6.16.2 Apotex Business Overview
  94. 6.16.3 Apotex Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Apotex Cinnarizine Product Portfolio
  96. 6.16.5 Apotex Recent Developments
  97. 6.17 Allena Pharmaceuticals
  98. 6.17.1 Allena Pharmaceuticals Company Information
  99. 6.17.2 Allena Pharmaceuticals Business Overview
  100. 6.17.3 Allena Pharmaceuticals Cinnarizine Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Allena Pharmaceuticals Cinnarizine Product Portfolio
  102. 6.17.5 Allena Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Cinnarizine Sales by Country
  2. 7.1.1 North America Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cinnarizine Sales by Country (2021-2026)
  4. 7.1.3 North America Cinnarizine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cinnarizine Market Size by Country
  6. 7.2.1 North America Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cinnarizine Market Size by Country (2021-2026)
  8. 7.2.3 North America Cinnarizine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cinnarizine Sales by Country
  2. 8.1.1 Europe Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cinnarizine Sales by Country (2021-2026)
  4. 8.1.3 Europe Cinnarizine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cinnarizine Market Size by Country
  6. 8.2.1 Europe Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cinnarizine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cinnarizine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cinnarizine Sales by Country
  2. 9.1.1 Asia-Pacific Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cinnarizine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cinnarizine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cinnarizine Market Size by Country
  6. 9.2.1 Asia-Pacific Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cinnarizine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cinnarizine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cinnarizine Sales by Country
  2. 10.1.1 South America Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cinnarizine Sales by Country (2021-2026)
  4. 10.1.3 South America Cinnarizine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cinnarizine Market Size by Country
  6. 10.2.1 South America Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cinnarizine Market Size by Country (2021-2026)
  8. 10.2.3 South America Cinnarizine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cinnarizine Sales by Country
  2. 11.1.1 Middle East and Africa Cinnarizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cinnarizine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cinnarizine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cinnarizine Market Size by Country
  6. 11.2.1 Middle East and Africa Cinnarizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cinnarizine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cinnarizine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cinnarizine Value Chain Analysis
  2. 12.1.1 Cinnarizine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cinnarizine Production Mode & Process
  7. 12.2 Cinnarizine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cinnarizine Distributors
  10. 12.2.3 Cinnarizine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research